Skip to main content
Top
Published in: Journal of Translational Medicine 1/2015

Open Access 01-12-2015 | Research

Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models

Authors: Inge M Worni-Schudel, Amy G Clark, Tiffany Chien, Kwan-Ki Hwang, Benny J Chen, Mary H Foster

Published in: Journal of Translational Medicine | Issue 1/2015

Login to get access

Abstract

Background

Anti-glomerular basement membrane nephritis and Goodpasture syndrome result from autoantibody (Ab)-mediated destruction of kidney and lung. Ab target the noncollagenous 1 (NC1) domain of alpha3(IV) collagen, but little is known about Ab origins or structure. This ignorance is due in part to the inability to recover monoclonal Ab by transformation of patients’ blood cells. The aim of this study was to assess the suitability of two humanized models for this purpose.

Methods

NOD-scid-gamma immunodeficient mice were engrafted either with human CD34+ hematopoietic stem cells (HSC) (Hu-HSC mice) and immunized with alpha3(IV)NC1 collagen containing the Goodpasture epitopes or with nephritis patients’ peripheral blood leukocytes (PBL) (Hu-PBL mice). After in vivo immune cell development and/or expansion, recovered human B cells were Epstein Barr virus (EBV)-transformed, screened for antigen (Ag) binding, electrofused with a mouse–human heterohybridoma, subcloned, and human Ab RNA sequenced by PCR after reverse transcription to cDNA. Flow cytometry was used to assess human B cell markers and differentiation in Hu-PBL mice.

Results

Sequence analysis of a human Ab derived from an immunized Hu-HSC mouse and reactive with alpha3(IV)NC1 collagen reveals that it is encoded by unmutated heavy and light chain genes. The heavy chain complementarity determining region 3, a major determinant of Ag binding, contains uncommon motifs, including an N-region somatically-introduced highly hydrophobic tetrapeptide and dual cysteines encoded by a uniquely human IGHD2-2 Ab gene segment that lacks a murine counterpart. Comparison of human and mouse autoantibodies suggests that structurally similar murine Ab may arise by convergent selection. In contrast to the Hu-HSC model, transformed human B cells are rarely recovered from Hu-PBL mice, in which human B cells terminally differentiate and lose expression of EBV receptor CD21, thus precluding their transformation and recovery.

Conclusions

Hu-HSC mice reveal that potentially pathogenic B cells bearing unmutated Ig receptors reactive with the NC1 domain on alpha3(IV) collagen can be generated in, and not purged from, the human preimmune repertoire. Uniquely human gene elements are recruited to generate the antigen binding site in at least a subset of these autoantibodies, indicating that humanized models may provide insights inaccessible using conventional mouse models.
Appendix
Available only for authorised users
Literature
1.
go back to reference Saus J, Wieslander J, Langeveld J, Quinones S, Hudson B (1988) Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem 263:13374–13380PubMed Saus J, Wieslander J, Langeveld J, Quinones S, Hudson B (1988) Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem 263:13374–13380PubMed
2.
go back to reference Turner N, Mason P, Brown R (1992) Molecular cloning of the Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest 89:592–601PubMedCentralPubMedCrossRef Turner N, Mason P, Brown R (1992) Molecular cloning of the Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest 89:592–601PubMedCentralPubMedCrossRef
3.
go back to reference Wilson C, Dixon F (1973) Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 3:74–89PubMedCrossRef Wilson C, Dixon F (1973) Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 3:74–89PubMedCrossRef
4.
go back to reference Lerner RA, Glassock RJ, Dixon FJ (1967) The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 126:989–1004PubMedCentralPubMedCrossRef Lerner RA, Glassock RJ, Dixon FJ (1967) The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 126:989–1004PubMedCentralPubMedCrossRef
5.
go back to reference Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG (2003) Alport’s syndrome, Goodpasture’s syndrome, and type IV collagen. N Engl J Med 348:2543–2556PubMedCrossRef Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG (2003) Alport’s syndrome, Goodpasture’s syndrome, and type IV collagen. N Engl J Med 348:2543–2556PubMedCrossRef
6.
go back to reference Borza DB, Netzer KO, Leinonen A, Todd P, Cervera J, Saus J et al (2000) The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J Biol Chem 275:6030–6037PubMedCrossRef Borza DB, Netzer KO, Leinonen A, Todd P, Cervera J, Saus J et al (2000) The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J Biol Chem 275:6030–6037PubMedCrossRef
7.
go back to reference Cui Z, Wang H, Zhao M (2006) Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int 69:894–899PubMedCrossRef Cui Z, Wang H, Zhao M (2006) Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int 69:894–899PubMedCrossRef
8.
go back to reference Cui Z, Zhao MH, Segelmark M, Hellmark T (2010) Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int 78:590–597PubMedCrossRef Cui Z, Zhao MH, Segelmark M, Hellmark T (2010) Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int 78:590–597PubMedCrossRef
9.
go back to reference Sado Y, Naito I, Akita M, Okigaki T (1986) Strain specific responses of inbred rats on the severity of experimental autoimmune glomerulonephritis. J Clin Lab Immunol 19:193–199PubMed Sado Y, Naito I, Akita M, Okigaki T (1986) Strain specific responses of inbred rats on the severity of experimental autoimmune glomerulonephritis. J Clin Lab Immunol 19:193–199PubMed
10.
go back to reference Reynolds J, Albouainain A, Duda MA, Evans DJ, Pusey CD (2006) Strain susceptibility to active induction and passive transfer of experimental autoimmune glomerulonephritis in the rat. Nephrol Dial Transplant 21:3398–3408PubMedCrossRef Reynolds J, Albouainain A, Duda MA, Evans DJ, Pusey CD (2006) Strain susceptibility to active induction and passive transfer of experimental autoimmune glomerulonephritis in the rat. Nephrol Dial Transplant 21:3398–3408PubMedCrossRef
11.
go back to reference Hopfer H, Maron R, Butzmann U, Helmchen U, Weiner HL, Kalluri R (2003) The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice. Faseb J 17:860–868PubMedCrossRef Hopfer H, Maron R, Butzmann U, Helmchen U, Weiner HL, Kalluri R (2003) The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice. Faseb J 17:860–868PubMedCrossRef
12.
go back to reference Luo W, Wang XP, Kashtan CE, Borza DB (2010) Alport alloantibodies but not Goodpasture autoantibodies induce murine glomerulonephritis: protection by quinary crosslinks locking cryptic alpha3(IV) collagen autoepitopes in vivo. J Immunol 185:3520–3528PubMedCentralPubMedCrossRef Luo W, Wang XP, Kashtan CE, Borza DB (2010) Alport alloantibodies but not Goodpasture autoantibodies induce murine glomerulonephritis: protection by quinary crosslinks locking cryptic alpha3(IV) collagen autoepitopes in vivo. J Immunol 185:3520–3528PubMedCentralPubMedCrossRef
13.
go back to reference Ryan JJ, Katbamna I, Mason PJ, Pusey CD, Turner AN (1998) Sequence analysis of the ‘Goodpasture antigen’ of mammals. Nephrol Dial Transplant 13:602–607PubMedCrossRef Ryan JJ, Katbamna I, Mason PJ, Pusey CD, Turner AN (1998) Sequence analysis of the ‘Goodpasture antigen’ of mammals. Nephrol Dial Transplant 13:602–607PubMedCrossRef
14.
go back to reference Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S et al (2005) Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174:6477–6489PubMedCrossRef Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S et al (2005) Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174:6477–6489PubMedCrossRef
15.
go back to reference Pearson T, Greiner DL, Shultz LD (2008) Creation of “humanized” mice to study human immunity. Curr Protoc Immunol 15(Suppl 81):15.21.1–15.21.21 Pearson T, Greiner DL, Shultz LD (2008) Creation of “humanized” mice to study human immunity. Curr Protoc Immunol 15(Suppl 81):15.21.1–15.21.21
16.
17.
go back to reference Bonsignori M, Hwang KK, Chen X, Tsao CY, Morris L, Gray E et al (2011) Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J Virol 85:9998–10009PubMedCentralPubMedCrossRef Bonsignori M, Hwang KK, Chen X, Tsao CY, Morris L, Gray E et al (2011) Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J Virol 85:9998–10009PubMedCentralPubMedCrossRef
18.
go back to reference Posner MR, Elboim H, Santos D (1987) The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies. Hybridoma 6:611–625PubMedCrossRef Posner MR, Elboim H, Santos D (1987) The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies. Hybridoma 6:611–625PubMedCrossRef
19.
go back to reference Yu X, McGraw PA, House FS, Crowe JE Jr (2008) An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J Immunol Methods 336:142–151PubMedCentralPubMedCrossRef Yu X, McGraw PA, House FS, Crowe JE Jr (2008) An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J Immunol Methods 336:142–151PubMedCentralPubMedCrossRef
20.
go back to reference Zhang Y, Su SC, Hecox DB, Brady GF, Mackin KM, Clark AG et al (2008) Central tolerance regulates B cells reactive with Goodpasture antigen alpha3(IV)NC1 collagen. J Immunol 181:6092–6100PubMedCentralPubMedCrossRef Zhang Y, Su SC, Hecox DB, Brady GF, Mackin KM, Clark AG et al (2008) Central tolerance regulates B cells reactive with Goodpasture antigen alpha3(IV)NC1 collagen. J Immunol 181:6092–6100PubMedCentralPubMedCrossRef
21.
go back to reference Liao HX, Levesque MC, Nagel A, Dixon A, Zhang R, Walter E et al (2009) High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J Virol Methods 158:171–179PubMedCentralPubMedCrossRef Liao HX, Levesque MC, Nagel A, Dixon A, Zhang R, Walter E et al (2009) High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J Virol Methods 158:171–179PubMedCentralPubMedCrossRef
22.
go back to reference Giudicelli V, Chaume D, Lefranc MP (2004) IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res 32:W435–W440PubMedCentralPubMedCrossRef Giudicelli V, Chaume D, Lefranc MP (2004) IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res 32:W435–W440PubMedCentralPubMedCrossRef
23.
go back to reference Yousfi Monod M, Giudicelli V, Chaume D, Lefranc MP (2004) IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs. Bioinformatics 20(Suppl 1):I379–I385PubMedCrossRef Yousfi Monod M, Giudicelli V, Chaume D, Lefranc MP (2004) IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs. Bioinformatics 20(Suppl 1):I379–I385PubMedCrossRef
24.
go back to reference Xu JL, Davis MM (2000) Diversity in the CDR3 region of VH Is sufficient for most antibody specificities. Immunity 13:37–45PubMedCrossRef Xu JL, Davis MM (2000) Diversity in the CDR3 region of VH Is sufficient for most antibody specificities. Immunity 13:37–45PubMedCrossRef
25.
go back to reference Zemlin M, Klinger M, Link J, Zemlin C, Bauer K, Engler JA et al (2003) Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J Mol Biol 334:733–749PubMedCrossRef Zemlin M, Klinger M, Link J, Zemlin C, Bauer K, Engler JA et al (2003) Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J Mol Biol 334:733–749PubMedCrossRef
26.
go back to reference Wu L, Oficjalska K, Lambert M, Fennell BJ, Darmanin-Sheehan A, Ni Shuilleabhain D et al (2012) Fundamental characteristics of the immunoglobulin VH repertoire of chickens in comparison with those of humans, mice, and camelids. J Immunol 188:322–333PubMedCrossRef Wu L, Oficjalska K, Lambert M, Fennell BJ, Darmanin-Sheehan A, Ni Shuilleabhain D et al (2012) Fundamental characteristics of the immunoglobulin VH repertoire of chickens in comparison with those of humans, mice, and camelids. J Immunol 188:322–333PubMedCrossRef
27.
go back to reference Ichiyoshi Y, Casali P (1994) Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segment. J Exp Med 180:885–895PubMedCrossRef Ichiyoshi Y, Casali P (1994) Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segment. J Exp Med 180:885–895PubMedCrossRef
28.
29.
go back to reference Boyd SD, Gaeta BA, Jackson KJ, Fire AZ, Marshall EL, Merker JD et al (2010) Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements. J Immunol 184:6986–6992PubMedCentralPubMedCrossRef Boyd SD, Gaeta BA, Jackson KJ, Fire AZ, Marshall EL, Merker JD et al (2010) Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements. J Immunol 184:6986–6992PubMedCentralPubMedCrossRef
30.
go back to reference Rajesh D, Zhou Y, Jankowska-Gan E, Roenneburg DA, Dart ML, Torrealba J et al (2010) Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rgammanull mice. Hum Immunol 71:551–559PubMedCentralPubMedCrossRef Rajesh D, Zhou Y, Jankowska-Gan E, Roenneburg DA, Dart ML, Torrealba J et al (2010) Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rgammanull mice. Hum Immunol 71:551–559PubMedCentralPubMedCrossRef
31.
go back to reference Biswas S, Chang H, Sarkis PT, Fikrig E, Zhu Q, Marasco WA (2011) Humoral immune responses in humanized BLT mice immunized with West Nile virus and HIV-1 envelope proteins are largely mediated via human CD5+ B cells. Immunology 134:419–433PubMedCentralPubMedCrossRef Biswas S, Chang H, Sarkis PT, Fikrig E, Zhu Q, Marasco WA (2011) Humoral immune responses in humanized BLT mice immunized with West Nile virus and HIV-1 envelope proteins are largely mediated via human CD5+ B cells. Immunology 134:419–433PubMedCentralPubMedCrossRef
32.
go back to reference Chen Q, He F, Kwang J, Chan JK, Chen J (2012) GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T, B, and dendritic cell maturation. J Immunol 189:5223–5229PubMedCentralPubMedCrossRef Chen Q, He F, Kwang J, Chan JK, Chen J (2012) GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T, B, and dendritic cell maturation. J Immunol 189:5223–5229PubMedCentralPubMedCrossRef
33.
go back to reference Willinger T, Rongvaux A, Takizawa H, Yancopoulos GD, Valenzuela DM, Murphy AJ et al (2011) Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc Natl Acad Sci USA 108:2390–2395PubMedCentralPubMedCrossRef Willinger T, Rongvaux A, Takizawa H, Yancopoulos GD, Valenzuela DM, Murphy AJ et al (2011) Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc Natl Acad Sci USA 108:2390–2395PubMedCentralPubMedCrossRef
34.
go back to reference Ooi JD, Chang J, O’Sullivan KM, Pedchenko V, Hudson BG, Vandenbark AA et al (2013) The HLA-DRB1*15:01-restricted Goodpasture’s T cell epitope induces GN. J Am Soc Nephrol 24:419–431PubMedCentralPubMedCrossRef Ooi JD, Chang J, O’Sullivan KM, Pedchenko V, Hudson BG, Vandenbark AA et al (2013) The HLA-DRB1*15:01-restricted Goodpasture’s T cell epitope induces GN. J Am Soc Nephrol 24:419–431PubMedCentralPubMedCrossRef
35.
go back to reference Sackey FN, Congdon KL, Brady GF, Hopfer H, Zhang Y, Mackin KM, Clark AG et al (2008) Shared variable domain elements among anti-collagen antibodies reactive with Goodpasture epitopes. In: Vogel FL, Zimmermann LF (eds) Autoimmunity: role, regulation and disorder. Nova Science Publishers, Inc., Hauppauge, pp 269–281 Sackey FN, Congdon KL, Brady GF, Hopfer H, Zhang Y, Mackin KM, Clark AG et al (2008) Shared variable domain elements among anti-collagen antibodies reactive with Goodpasture epitopes. In: Vogel FL, Zimmermann LF (eds) Autoimmunity: role, regulation and disorder. Nova Science Publishers, Inc., Hauppauge, pp 269–281
36.
go back to reference Hunze EM (2013) Generation of recombinant factor H proteins to control alternative pathway activation in the kidney. PhD thesis, Newcastle University, Institute of Cellular Medicine Hunze EM (2013) Generation of recombinant factor H proteins to control alternative pathway activation in the kidney. PhD thesis, Newcastle University, Institute of Cellular Medicine
37.
go back to reference Wilkinson RA, Piscitelli C, Teintze M, Cavacini LA, Posner MR, Lawrence CM (2005) Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120. J Virol 79:13060–13069PubMedCentralPubMedCrossRef Wilkinson RA, Piscitelli C, Teintze M, Cavacini LA, Posner MR, Lawrence CM (2005) Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120. J Virol 79:13060–13069PubMedCentralPubMedCrossRef
38.
go back to reference de Bono B, Madera M, Chothia C (2004) VH gene segments in the mouse and human genomes. J Mol Biol 342:131–143PubMedCrossRef de Bono B, Madera M, Chothia C (2004) VH gene segments in the mouse and human genomes. J Mol Biol 342:131–143PubMedCrossRef
39.
go back to reference Meyers KE, Christensen M, Madaio MP (2009) Modeling of human anti-GBM antibody-alpha3(IV)NC1 interactions predicts antigenic cross-linking through contact of both heavy chains with repeating epitopes on alpha3(IV)NC1. Am J Nephrol 30:474–480PubMedCentralPubMedCrossRef Meyers KE, Christensen M, Madaio MP (2009) Modeling of human anti-GBM antibody-alpha3(IV)NC1 interactions predicts antigenic cross-linking through contact of both heavy chains with repeating epitopes on alpha3(IV)NC1. Am J Nephrol 30:474–480PubMedCentralPubMedCrossRef
40.
go back to reference Meyers KE, Kinniry PA, Kalluri R, Neilson EG, Madaio MP (1998) Human Goodpasture anti-alpha3(IV)NC1 autoantibodies share structural determinants. Kidney Int 53:402–407PubMedCrossRef Meyers KE, Kinniry PA, Kalluri R, Neilson EG, Madaio MP (1998) Human Goodpasture anti-alpha3(IV)NC1 autoantibodies share structural determinants. Kidney Int 53:402–407PubMedCrossRef
41.
go back to reference Stevens RH, Macy E, Morrow C, Saxon A (1979) Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization. J Immunol 122:2498–2504PubMed Stevens RH, Macy E, Morrow C, Saxon A (1979) Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization. J Immunol 122:2498–2504PubMed
42.
go back to reference Ifversen P, Borrebaeck CA (1996) SCID-hu-PBL: a model for making human antibodies? Semin Immunol 8:243–248PubMedCrossRef Ifversen P, Borrebaeck CA (1996) SCID-hu-PBL: a model for making human antibodies? Semin Immunol 8:243–248PubMedCrossRef
43.
go back to reference Lefranc MP, Pommie C, Ruiz M, Giudicelli V, Foulquier E, Truong L et al (2003) IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol 27(1):55–77PubMedCrossRef Lefranc MP, Pommie C, Ruiz M, Giudicelli V, Foulquier E, Truong L et al (2003) IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol 27(1):55–77PubMedCrossRef
Metadata
Title
Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models
Authors
Inge M Worni-Schudel
Amy G Clark
Tiffany Chien
Kwan-Ki Hwang
Benny J Chen
Mary H Foster
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2015
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-015-0539-4

Other articles of this Issue 1/2015

Journal of Translational Medicine 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.